Delivery Order SPE2DB24D2205-SPE2DB24FDZTY

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $1,357.61 firm-fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive product. The order has an ultimate completion date of August 30, 2024. AmerisourceBergen is the prime contractor, and there are no set-aside designations noted. This award is likely part of a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $8,064.59 contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The award has a completion date of September 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $9,737.40 firm fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive product. The delivery order has an ultimate completion date of August 30, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,137.76 Firm Fixed Price Delivery Order contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract has an ultimate completion date of September 27, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen, the prime...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a leading pharmaceutical distributor in the United States. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch, under a Firm Fixed Price Delivery Order valued at $6,216.86. The contract has an ultimate completion date of September 20, 2024. AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,108.07 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The contract has an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XULANE 150-35 MCG/DAY Patch 3S, a contraceptive medication. The $3,024.42 fixed-price contract has a completion date of January 5, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,657.38 firm fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,746.23 contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The award has an ultimate completion date of July 5, 2023 and is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $4,595.50 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that DLA Troop Support Medical has with Amerisourcebergen, valued up to $999,999,999 through December 2025, for providing a wide range of pharmaceutical and medical supplies to support military...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDZTY
    Delivery Order

This is a $13,749.41 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication, with a period of performance through September 12, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded this contract as well as other Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation for the provision of a wide range of pharmaceutical and medical supplies to support military, veterans, and other federal healthcare programs. This particular award does not utilize any set-aside designations.

Generated 12/11/24, 9:35 AM